References
- Harley H G, Brook J D, Rundle S A, Crow S, Reardon W, Buckler A J, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992; 355: 545–546
- Harper P S. Myotonic disorders. Myology, A G Engl, B Q Baker. McGraw-Hill, New York 1986; 1276–1296
- Gruener R, Stern L Z, Markovitz D, Gerds C. Electrophysiologic properties of intercostal muscle fibres in human neuromuscular diseases. Muscle and Nerve 1979; 2: 165–172
- Rüdel R, Dengler R, Ricker K, Haass A, Emser W. Improved therapy of myotonia with the lidocaine derivative tocainide. J Neurol 1980; 222: 275–280
- Mielke U, Haass A, Sen S, Schmidt W. Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert. J Neurol 1985; 232: 271–274
- Davidson S I. The eye in myotonic dystrophy. Br J Ophthalmol 1961; 45: 183–195
- Burian H M, Burns C A. Ocular changes in myotonic dystrophy. Am J Ophthalmol 1967; 63: 22–34
- Caughey J E, Myrianthopoulos N L. Dystrophia Myotonica and Related Disorders. Charles C Thomas, Springfield, IL 1963
- Babel J. Ophthalmological aspects of myotonic dystrophy. Neurogenetics and Neuro-Ophthalmology, A Huber, D Klein. North Holland/Elsevier, Amsterdam/New York 1981; 19–30
- Maas O, Patterson A S. The identity of myotonia congenita (Thomsen's disease), dystrophia myotonica (myotonica atrophica) and paramyotonia. Brain 1939; 62: 198–212
- Walton J N, Nattrass F J. On the classification, natural history, and treatment of the myopathies. Brain 1954; 77: 169–231
- Rosman N P, Kukulas B A. Mental deficiency associated with muscular dystrophy. A neuropathological study. Brain 1966; 89: 769–788
- Walsh F B, Hoyt W F. Clinical Neuro-Ophthalmology, 3rd edn. Williams and Wilkins, Baltimore 1969; 1273–1274
- Lessell S, Coppeto J, Samet S. Ophthalmoplegia in myotonic dystrophy. Am J Ophthalmol 1971; 71: 1231–1235
- Dyken P R. Extraocular myotonia in families with dystrophia mytonica. Neurology 1966; 16: 738–740
- Verbiest H. Observations sur la mecanisme de la convergence myotonique dans un cas de la maladie de Steinert. Rev Neurol (Paris) 1937; 67: 387–390
- Zangemeister W H, Müller-Jensen A. Electrookulographische Befunde bei Myotonic. Forschritte der Myologie. 1978; 129–139, Proceedings of the Fourth Symposium des wissenschaftlichen Beirates of the Deutsche Gesellschaft für Bekampfung der Muskelkrankheiten e. V.
- Baloh R W, Konrad H R, Sills A WW, Honrubia V H. The saccade velocity test. Neurology 1985; 25: 1071–1076
- Oohira A, Goto K, Ozawa T. Slow saccades in myogenic and peripheral ophthalmoplegia. Latent ocular myopathy in myotonic dystrophy. Neuro-Ophthalmology 1985; 5: 117–123
- Ter Bruggen J P, Bastiaensen L AK, Tyssen C C, Gielen G. Disorders of eye movement in myotonic dystrophy. Brain 1990; 113: 463–473
- Von Noorden G K, Thompson H S, Van Allen M W. Eye movements in myotonic dystrophy. An electrooculographic study. Invest Ophthalmol 1964; 3: 314–324
- Emre M, Henn V. Central eye movement disorder in a case of myotonic dystrophy. Neuro-Ophthalmology 1985; 5: 21–25
- Oohira A, Ozawa T. Eye movement disorders in myotonic dystrophy. Nippon Ganka Gakkai Sasshi 1982; 86: 540–546
- Lueck C J, Crawford T J, Hansen H C, Kennard C. Increase in saccadic peak velocity with increased frequency of saccades in man. Vision Res 1991; 31: 1439–1443
- Reulen J PH, Marcus J T, Koops D, De Vries F R, Tiesinga G, Boshuizen K, Bos J E. Precise recording of eye movement: the IRIS technique, part 1. Med Biol Eng Comp 1988; 26: 20–26
- Cooper R G, Stokes M J, Edwards R HT. Physiological characterisation of the ‘warm up’ effect of activity in patients with myotonic dystrophy. J Neurol Neurosurg Psychiat 1988; 51: 1134–1141
- Burns C A. Ocular histopathology of myotonic dystrophy. Am J Ophthalmol 1969; 68: 417–422
- Kuwabara T, Lessell S. Electron microscopic study of extraocular muscles in myotonic dystrophy. Am J Ophthalmol 1976; 82: 303–309
- Ginsberg J, Hamblet J, Menefee M. Ocular abnormality in myotonic dystrophy. Ann Ophthalmol 1978; 10: 1021–1028
- Dengler R, Rüdel R. Effects of tocainide on normal and myotonic mammalian skeletal muscle. Arzneimittel-Forsch/ Drug Research 1979; 29: 270–273